Daiwa Securities Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.8M Buy
77,325
+5,279
+7% +$2.53M 0.08% 147
2026
Q1
$35.4M Buy
72,046
+2,691
+4% +$1.46M 0.1% 109
2025
Q4
$40.2M Sell
69,355
-3,320
-5% -$1.88M 0.13% 105
2025
Q3
$35.2M Sell
72,675
-7,401
-9% -$3.44M 0.12% 113
2025
Q2
$32.5M Buy
80,076
+16,319
+26% +$6.82M 0.12% 114
2025
Q1
$31.7M Buy
63,757
+3,329
+6% +$1.8M 0.13% 104
2024
Q4
$31.4M Buy
60,428
+3,700
+7% +$2.03M 0.14% 95
2024
Q3
$35.1M Sell
56,728
-235
-0.4% -$139K 0.16% 88
2024
Q2
$31.5M Buy
56,963
+1,518
+3% +$870K 0.17% 86
2024
Q1
$32.2M Sell
55,445
-1,129
-2% -$634K 0.18% 82
2023
Q4
$30M Buy
56,574
+1,985
+4% +$961K 0.19% 78
2023
Q3
$27.6M Buy
54,589
+2,100
+4% +$1.12M 0.2% 74
2023
Q2
$27.4M Sell
52,489
-1,959
-4% -$1.06M 0.18% 76
2023
Q1
$31.4M Buy
54,448
+814
+2% +$459K 0.22% 59
2022
Q4
$29.5M Buy
53,634
+438
+0.8% +$232K 0.23% 59
2022
Q3
$27M Sell
53,196
-5,853
-10% -$3.28M 0.22% 55
2022
Q2
$32.1M Sell
59,049
-2,900
-5% -$1.6M 0.25% 50
2022
Q1
$36.6M Sell
61,949
-3,536
-5% -$2.03M 0.23% 54
2021
Q4
$43.7M Buy
65,485
+11,851
+22% +$7.4M 0.26% 53
2021
Q3
$30.6M Buy
53,634
+31,171
+139% +$17.1M 0.2% 62
2021
Q2
$11.3M Buy
22,463
+83
+0.4% +$39.2K 0.08% 133
2021
Q1
$10.2M Buy
22,380
+531
+2% +$253K 0.08% 128
2020
Q4
$10.2M Buy
21,849
+208
+1% +$97.5K 0.08% 124
2020
Q3
$9.55M Buy
21,641
+1,076
+5% +$445K 0.09% 104
2020
Q2
$258K Hold
20,565
0.01% 717
2020
Q1
$5.83M Buy
20,565
+418
+2% +$132K 0.06% 146
2019
Q4
$6.55M Sell
20,147
-4,219
-17% -$1.28M 0.05% 163
2019
Q3
$7.1M Sell
24,366
-456
-2% -$131K 0.06% 150
2019
Q2
$7.29M Buy
24,822
+2,225
+10% +$613K 0.06% 135
2019
Q1
$6.18M Sell
22,597
-2,416
-10% -$601K 0.05% 151
2018
Q4
$5.6M Sell
25,013
-16,927
-40% -$3.97M 0.05% 159
2018
Q3
$10.2M Sell
41,940
-8,129
-16% -$1.87M 0.09% 120
2018
Q2
$10.4M Buy
50,069
+2,369
+5% +$503K 0.08% 123
2018
Q1
$9.85M Buy
47,700
+4,606
+11% +$967K 0.08% 128
2017
Q4
$8.18M Sell
43,094
-6,539
-13% -$1.25M 0.06% 172
2017
Q3
$9.39M Buy
49,633
+38,383
+341% +$6.95M 0.06% 138
2017
Q2
$1.96M Buy
11,250
+150
+1% +$25.2K 0.01% 325
2017
Q1
$1.71M Buy
11,100
+1,000
+10% +$153K 0.01% 365
2016
Q4
$1.43M Buy
10,100
+106
+1% +$15.6K 0.01% 344
2016
Q3
$1.59M Hold
9,994
0.01% 341
2016
Q2
$1.48M Buy
9,994
+200
+2% +$29.5K 0.01% 339
2016
Q1
$1.39M Sell
9,794
-200
-2% -$26.8K 0.01% 334
2015
Q4
$1.42M Sell
9,994
-100
-1% -$13.3K 0.01% 302
2015
Q3
$1.24M Buy
10,094
+100
+1% +$13K 0.01% 329
2015
Q2
$1.3M Buy
9,994
+200
+2% +$26.1K 0.01% 347
2015
Q1
$1.31M Sell
9,794
-600
-6% -$77.3K 0.01% 304
2014
Q4
$1.3M Sell
10,394
-900
-8% -$109K 0.01% 294
2014
Q3
$1.37M Sell
11,294
-600
-5% -$73K 0.01% 257
2014
Q2
$1.4M Buy
11,894
+500
+4% +$58.8K 0.01% 257
2014
Q1
$1.37M Sell
11,394
-3,000
-21% -$357K 0.01% 268
2013
Q4
$1.6M Buy
14,394
+400
+3% +$39.8K 0.01% 219
2013
Q3
$1.29M Sell
13,994
-200
-1% -$18.1K 0.01% 247
2013
Q2
$1.2M Buy
+14,194
New +$1.18M 0.01% 267

Other funds holding TMO

Daiwa Securities Group's TMO Position: Q2 2026 in Review

Daiwa Securities Group increased its Thermo Fisher Scientific (TMO) stake by 7.3% in Q2 2026, buying an estimated $2.53M and bringing the position to 77,325 shares worth $38.8M. The position accounts for 0.08% of the portfolio, ranked #147.

Daiwa Securities Group first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $43.7M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Daiwa Securities Group held 77,325 shares of Thermo Fisher Scientific worth $38.8M as of Q2 2026.
  • Daiwa Securities Group bought 5,279 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.53M.
  • Thermo Fisher Scientific made up 0.08% of Daiwa Securities Group's portfolio in Q2 2026, its #147 holding.
  • Daiwa Securities Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Daiwa Securities Group's Thermo Fisher Scientific position peaked at $43.7M in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.